ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,354.03
0.00%
US Tech 100
18,530.40
-0.06%
다우존스 지수
38,807.33
0.00%
Bitcoin
71,108.93
0.04%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Guardant Health Inc (GH)

  7. Guardant Health Inc (GH) 뉴스

GH

Guardant Health (GH)

Guardant Health Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:GH
일자시간출처헤드라인심볼기업
2024/06/0605:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
2024/06/0505:12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GHGuardant Health Inc
2024/06/0421:05Business WireGuardant Health introduces new Guardant360 TissueNext test with nearly 500 biomarkers to identify more treatment options for patients with advanced cancerNASDAQ:GHGuardant Health Inc
2024/06/0407:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
2024/06/0407:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
2024/06/0407:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
2024/06/0322:18Business WireGuardant Health and Washington University to present study at 2024 ASCO meeting highlighting utility of ctDNA to address racial inequities in the use of targeted therapies and enrollment in clinical trialsNASDAQ:GHGuardant Health Inc
2024/06/0105:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GHGuardant Health Inc
2024/05/3121:05Business WireGuardant Health Named to TIME100 Most Influential CompaniesNASDAQ:GHGuardant Health Inc
2024/05/3021:05Business WireGuardant Health to Present Studies at 2024 ASCO Annual Meeting Highlighting Contributions of Its Blood Tests and Real-World Data to Advancing Precision Oncology and Cancer ScreeningNASDAQ:GHGuardant Health Inc
2024/05/2420:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GHGuardant Health Inc
2024/05/2408:03Business WireFDA Advisory Committee Panel Strongly Recommends Approval of Shield™ Blood Test for Colorectal Cancer Screening as a Primary Non-Invasive Screening OptionNASDAQ:GHGuardant Health Inc
2024/05/2320:05Business WireGuardant Health Stock Trading Temporarily Halted; FDA Panel to Assess Premarket Approval Application for Shield Blood Test for Colorectal Cancer ScreeningNASDAQ:GHGuardant Health Inc
2024/05/2305:05Business WireGuardant Health to Participate in Upcoming Investor ConferencesNASDAQ:GHGuardant Health Inc
2024/05/2121:44Business WireGuardant Health erhält EU-IVDR-Zertifizierung für Flüssigbiopsie Guardant360® CDx zur Erstellung von Tumormutationsprofilen für alle soliden Krebsarten und therapiebegleitende Diagnostika-IndikationenNASDAQ:GHGuardant Health Inc
2024/05/2121:44Business WireGuardant Health reçoit la certification IVDR de l’UE pour la biopsie liquide Guardant360® CDx destinée au profilage des mutations tumorales dans tous les cancers solides et les indications de diagnostic compagnonNASDAQ:GHGuardant Health Inc
2024/05/2121:05Business WireGuardant Health Receives EU IVDR Certification for Guardant360® CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic IndicationsNASDAQ:GHGuardant Health Inc
2024/05/1721:05Business WireGuardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GHGuardant Health Inc
2024/05/1707:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
2024/05/1707:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
2024/05/1621:05Business WireGuardant Health to present real-world data supporting performance of Shield™ blood test for colorectal cancer screening at 2024 Digestive Disease WeekNASDAQ:GHGuardant Health Inc
2024/05/1005:59Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GHGuardant Health Inc
2024/05/1005:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GHGuardant Health Inc
2024/05/1005:05Business WireGuardant Health Reports First Quarter 2024 Financial Results and Increases 2024 Revenue GuidanceNASDAQ:GHGuardant Health Inc
2024/05/0805:05Business WireGuardant Health to Participate in Upcoming Investor ConferencesNASDAQ:GHGuardant Health Inc
2024/05/0721:00Business WireGuardant Health Surpasses 500 Peer-Reviewed Publications MilestoneNASDAQ:GHGuardant Health Inc
2024/05/0706:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
2024/05/0706:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
2024/05/0706:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
2024/04/2221:52Business WireFDA Advisory Panel Review of Guardant Health’s Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23NASDAQ:GHGuardant Health Inc
 검색 관련기사 보기:NASDAQ:GH

최근 히스토리

AMEX
XLE
Energy Select Sector SPDR
CCOM
SILVER
SILVER
NASDAQ
GOOGL
Alphabet
AMEX
XLV
Health Care Select Sector
NASDAQ
TSLA
Tesla
COIN
ETHUSD
Ethereum
NYSE
MCD
McDonalds
FX
USDJPY
US Dollar vs Yen
NYSE
DIS
Walt Disney
USI
USTECH100
US Tech 100
NYSE
NKE
Nike
SPI
SP500
S&P 500
COIN
SOLUSD
Solana
CCOM
US500
US 500
NYSE
AXP
American Express
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유